Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,500
Closed -$1.22M 5613
2024
Q4
$1.22M Hold
10,500
﹤0.01% 3246
2024
Q3
$1.42M Buy
+10,500
New +$1.4M ﹤0.01% 3124
2020
Q2
Sell
-1,000
Closed -$65K 6340
2020
Q1
$65K Sell
1,000
-1,600
-62% -$126K ﹤0.01% 5066
2019
Q4
$205K Buy
2,600
+900
+53% +$70K ﹤0.01% 5012
2019
Q3
$135K Buy
1,700
+400
+31% +$31.4K ﹤0.01% 5255
2019
Q2
$109K Sell
1,300
-100
-7% -$7.97K ﹤0.01% 5624
2019
Q1
$111K Sell
1,400
-10,700
-88% -$781K ﹤0.01% 5277
2018
Q4
$807K Buy
12,100
+3,300
+38% +$228K ﹤0.01% 3330
2018
Q3
$703K Sell
8,800
-1,100
-11% -$82.1K ﹤0.01% 3979
2018
Q2
$667K Buy
9,900
+7,900
+395% +$574K ﹤0.01% 3675
2018
Q1
$154K Sell
2,000
-5,100
-72% -$377K ﹤0.01% 5060
2017
Q4
$484K Sell
7,100
-1,100
-13% -$73K ﹤0.01% 3864
2017
Q3
$514K Sell
8,200
-8,300
-50% -$496K ﹤0.01% 3599
2017
Q2
$915K Buy
16,500
+5,400
+49% +$281K ﹤0.01% 2964
2017
Q1
$557K Buy
11,100
+1,100
+11% +$53.6K ﹤0.01% 3299
2016
Q4
$495K Buy
10,000
+9,700
+3,233% +$492K ﹤0.01% 3386
2016
Q3
$16K Sell
300
-800
-73% -$39.2K ﹤0.01% 5588
2016
Q2
$49K Sell
1,100
-2,600
-70% -$113K ﹤0.01% 4847
2016
Q1
$148K Buy
3,700
+2,200
+147% +$81K ﹤0.01% 4073
2015
Q4
$54K Sell
1,500
-900
-38% -$32.5K ﹤0.01% 4750
2015
Q3
$77K Sell
2,400
-800
-25% -$26.9K ﹤0.01% 4781
2015
Q2
$118K Buy
3,200
+1,200
+60% +$43.7K ﹤0.01% 4552
2015
Q1
$70K Sell
2,000
-34,000
-94% -$1.2M ﹤0.01% 5070
2014
Q4
$1.37M Sell
36,000
-3,300
-8% -$121K ﹤0.01% 2894
2014
Q3
$1.38M Sell
39,300
-261,500
-87% -$9.72M ﹤0.01% 3016
2014
Q2
$11.7M Buy
300,800
+256,000
+571% +$9.56M 0.01% 1029
2014
Q1
$1.61M Buy
44,800
+43,800
+4,380% +$1.6M ﹤0.01% 2759
2013
Q4
$34K Sell
1,000
-4,900
-83% -$158K ﹤0.01% 6436
2013
Q3
$159K Sell
5,900
-2,300
-28% -$61.3K ﹤0.01% 5241
2013
Q2
$221K Buy
+8,200
New +$226K ﹤0.01% 5077

Other funds holding XYL

Barclays's XYL Position: Q1 2026 in Review

Barclays increased its Xylem (XYL) stake by 30% in Q1 2026, buying an estimated $22.6M and bringing the position to 739,023 shares worth $88.3M. The position accounts for 0.02% of the portfolio, ranked #531.

Barclays first reported a position in XYL in Q2 2013 and has held it in 52 quarters since. The position peaked at $98.5M in Q3 2025. 1,108 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Barclays held 739,023 shares of Xylem worth $88.3M as of Q1 2026.
  • Barclays bought 172,190 Xylem shares in Q1 2026, an estimated $22.6M.
  • Xylem made up 0.02% of Barclays's portfolio in Q1 2026, its #531 holding.
  • Barclays first reported a position in Xylem in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Xylem position peaked at $98.5M in Q3 2025.
  • 1,108 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.